Background

Obstructive sleep apnea (OSA) is known as recurrent obstruction of the upper airway causing intermittent hypoxemia and fragmentation of sleep caused by arousals [1]. About 13% of males and 6% of females have moderate to severe OSA, more often in old age and individuals with high body mass index [2]. Most manifestations comprise daytime sleepiness, snoring, and sleep interruption. OSA is found in 26% of adults between 30 and 70 years old [3].

The severity of OSA can be defined by the number of apneas or hypopneas and the number of oxygen desaturation episodes recorded per hour of sleep [4].

Intermittent hypoxia in patients with obstructive sleep apnea results in increased oxidative stress and free radical production, which could explain endothelial dysfunction, increased sympathetic activity, systemic inflammatory response, and impaired glucose and lipid metabolism [5].

Methods

This retrospective research comprised 120 patients diagnosed with OSA who came to the Chest Department at Benha University Hospital from September 2021 to December 2022. Patients were ≥ 18 years old and came to the sleep laboratory due to questionable sleep-breathing abnormalities. Exclusion criteria included the presence of infection, the wound on the skin in contact with electrodes, contact allergy, significant neurological disease, and medications influencing sleep.

Full history taking and physical examination including body mass index were done for all included patients, full sleep polysomnography, and blood samples for CBC, ESR, and lipid profile.

Determination of obstructive sleep apnea and its severity was done by polysomnography, performed with the Alice Four Sleep System (Respironics Inc., Murrysville, PA, USA). Sleep parameters were evaluated per the 2007 American Academy of Sleep Medicine (AASM) protocol (Berry et al., 2012). Apnea–hypopnea index (AHI — the number of apneas or hypopneas recorded per hour of sleep) was derived from level 1 polysomnography (PSG).

Discontinuation of airflow or decrease > 90% lasting 10 or more seconds was used for defining apnea, and a decrease of > 30% in airflow associated with 3% or 4% oxygen desaturation was used for defining hypopnea. Mild sleep apnea was described by AHI between 5 and 14, moderate sleep apnea was delineated by AHI between 15 and 29, while the patients with AHI more than 30 had severe sleep apnea.

Oxygen desaturation index (ODI): The number of dips in So2 > 3 or 4% from baseline is divided by total sleep time. The pulse oximeter was attached to the index finger of the nondominant hand.

Statistical analysis

The program used was SPSS version 20. Quantitative data were analyzed using mean and standard deviation, while frequency and percentage were used with qualitative data. The chi-square test to compare frequencies and analysis of variance (ANOVA) was used to compare means. Pearson correlation found the relationship between variables and then logistic regression to predict the most dependent factor. P-value was considered significant if it was ≤ 0.05.

Results

A total of 120 patients were included in the study. Most cases were severe OSA (70%). In severe obstructive sleep apnea, the mean age was 44.04 with SD 9.49, males were 92.9%, and the mean BMI was 36.63 with SD 7.79. LDL was positively correlated with AHI and DI (significantly); triglycerides were positively correlated with AHI, DI, and min oxygen saturation (significantly); and HDL was negatively correlated with AHI and DI significantly.

Among lipid profile variables, LDL was the most predictor for AHI severity.

(1) Comparison between mild, moderate, and severe levels of ASA according to different variables

 

Mild (14)

Moderate (22)

Severe (84)

ANOVA

p-value

Mean

SD

Mean

SD

Mean

SD

Age

43.79

14.59

45.95

8.72

44.04

9.49

0.343

0.71

BMI

31.67

4.64

33.85

3.86

36.63

7.79

3.87

0.024*

DI

15.16

13.82

22.14

10.82

68.17

28.01

50.34

< 0.001**

MIN DES

82.5

7.87

79.68

6.79

76.0

8.03

5.29

0.006**

LDL

105.63

36.68

114.59

25.76

141.66

29.05

13.96

< 0.001**

HDL

45.79

9.45

39.31

10.90

38.46

6.19

5.52

0.005**

TG

138.9

59.24

175.96

73.05

199.96

100.13

2.89

0.059

(2) Correlation between LDL, HDL, TG, and different variables

 

LDL

HDL

TG

r

P

r

P

r

P

BMI

− 0.156

0.088

− 0.157

0.087

0.05

0.588

AHI

0.416

< 0.001**

− 0.278

0.002**

0.334

0.001**

DI

0.265

0.003**

− 0.248

0.006**

0.335

< 0.001**

MIN DES

− 0.023

0.802

0.037

0.684

− 0.213

0.019*

(3) Logistic regression to predict the most dependent factor affecting AHI

AHI

Exp (b)

P

LL 95% CI

UL 95% CI

BMI

1.11

0.01*

1.02

1.20

LDL

1.04

< 0.001**

1.02

1.07

HDL

0.968

0.407

0.895

1.05

TG

1.0

0.245

0.997

1.01

Discussion

Preceding research found a significant association between obstructive sleep apnea severity and lipid profile defects [6, 7]. Extremely raised cholesterol or triacylglycerols is accompanied by increased cardiovascular risk, chiefly due to the rapidity of the atherosclerotic process. However, it is found that aberrant lipid elimination may be accountable for this process due to the reduced action of lipoprotein lipase and consequent confirmation of LDL subclass B, which by oxidation causes rapid vascular damage [8].

The action of lipoprotein lipase is maintained by insulin and lowered by epinephrin and cortisol. This caused different research to highlight the role of insulin resistance and increased sympathetic activity as major pathological mechanisms related to obstructive sleep apnea [9, 10]. Similarly, diverse animal models found that the existence and severity of intermittent hypoxia are significantly correlated to hyperlipidemia and liver oxidative stress, causing raised lipolysis and diminished lipoprotein clearance [11].

The current work aimed to correlate lipid abnormalities with the severity of obstructive sleep apnea. This study on 120 patients with newly diagnosed obstructive sleep apnea showed a significant correlation between lipid abnormalities and obstructive sleep apnea severity. In our study, lipid abnormalities associated with OSA severity were triglycerides, high-density lipoprotein (HDL), and low-density lipoprotein (LDL). These lipid abnormalities were more obvious in patients with severe obstructive sleep apnea (AHI ≥ 30 per h). LDL was positively correlated with the apnea–hypopnea index and desaturation index (in statistically significant value).

Triglycerides were positively correlated with the apnea-hypopnea index, desaturation index, and minimum oxygen desaturation. HDL was negatively correlated with AHI and DI (in statistically significant value). In the current work, LDL was the most predictor variable for AHI severity. Guscoth et al. (2021) found a relationship between triglycerides and the severity of obstructive sleep apnea even in patients without central adiposity which was highly significant [12].

The chief mechanisms included in increased cholesterol and triglyceride levels in patients with OSA have increased hepatic triglyceride and cholesterol production, decreased clearance by lipase activity inhibition, and raised free fatty acid mobilization from adipose tissue [13]. Intermittent hypoxia commences overexpression of significant transcription factors in the course of cholesterol and triglyceride biosynthesis [14].

Patients with insulin resistance showed increased lipid levels especially those with severe forms of OSA [15]. In a study done by Togeiro et al. (2013), triglyceride levels were remarkable as a solid index of periodic hypoxia, solely related to AHI [16].

Popadi et al. (2022) found a substantial relationship between HDL with OSA severity, implying that patients with decreased HDL levels have increased apnea–hypopnea index (AHI) [17]. Regarding the defensive cardiovascular effects of high-density lipoproteins (HDL), it is found that definite subfractions of HDL, particularly small HDL subfractions involving small LDL3–7 and small HDL8–10, can have atherogenic consequences in patients with OSA [18].

Alternately, bigger HDL subfractions can have disabled antioxidant action due to raised HDL lipid peroxide degree and diminished serum paraoxonase-1 (PON1) activity, which are the two chief elements causing the antioxidant activity of HDL [19]. This could be a conceivable illustration of insufficient proof of the defensive effects of HDL in patients with OSA, even in patients with average HDL levels. Cases with diminished antioxidant HDL activity similarly had raised tumor necrosis factor-α (TNF-α) and intercellular adhesion molecule 1 (ICAM-1) values denoting raised systemic inflammation in severe OSA [20]. Research by Koseoglu et al. (2018) implied the compelling role of monocyte to HDL ratio as a possible criterion of OSA severity and its relationship with raised cardiovascular risk [21].

Conclusion

Patients with risk factors for severe forms of OSA, including gender and body mass index, should promptly be evaluated for OSA for management and to reduce the risk of various complications. Also, patients diagnosed with obstructive sleep apnea, especially severe ones, should be screened for lipid profiles to correct any abnormality and protect from long-term harmful effects of their increased level.

The drawbacks of this study were a small sample size, and not discussing hyperglycemia and HTN besides lipid profile.